Literature DB >> 33407142

Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?

Xiaoqing Zhang1, Wenwen Zhai1, Min Li1, Xiangyang Guo2.   

Abstract

BACKGROUND: Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prevent wound infection. However, VCM could lead to infusion rate-dependent antibody-and complement-independent anaphylaxis reaction by inducing direct release of histamine. CASE
PRESENTATION: We retrospectively analyzed seven cases of severe hypotension and shock during wound closure or immediately after orthopedic surgery with unidentifiable reasons. We found that these cases were all associated with local application of VCM powder during wound closure process. Two patients experienced sudden cardiac arrest. Most of the cases (6/7) with circulatory collapse were discharged without severe sequelae. While one case with application of 3 g VCM developed cardiac arrest and remained in a coma due to hypoxic-hypoxic encephalopathy. The clinical presentations and the time of the shock onset were considered to be related with a VCM induced anaphylaxis reaction. However, as this was a retrospective study, and there was no laboratory examination performed, the conclusion was made upon differential diagnosis based on clinical manifestations and the timing of the shock.
CONCLUSIONS: Local application of VCM may not be as safe as was once believed and may lead to a related anaphylaxis. As VCM induced infusion-rate dependent, non-IgE mediated anaphylaxis is characterized by delayed occurrence, severe hypotension and even circulatory collapse, surgeons and anesthesiologists should be extra vigilant during and after VCM application.

Entities:  

Keywords:  Anaphylaxis; Hypotension; Shock; Vancomycin

Mesh:

Substances:

Year:  2021        PMID: 33407142      PMCID: PMC7786494          DOI: 10.1186/s12871-020-01220-6

Source DB:  PubMed          Journal:  BMC Anesthesiol        ISSN: 1471-2253            Impact factor:   2.217


  26 in total

1.  Pharmacokinetics of vancomycin in neonates admitted to the neonatology unit at the Jordan University Hospital.

Authors:  E F Badran; A Shamayleh; Y M Irshaid
Journal:  Int J Clin Pharmacol Ther       Date:  2011-04       Impact factor: 1.366

2.  Experience with intrawound vancomycin powder for spinal deformity surgery.

Authors:  Joel R Martin; Owoicho Adogwa; Christopher R Brown; Carlos A Bagley; William J Richardson; Shivanand P Lad; Maragatha Kuchibhatla; Oren N Gottfried
Journal:  Spine (Phila Pa 1976)       Date:  2014-01-15       Impact factor: 3.468

Review 3.  Shock.

Authors:  David A Wacker; Michael E Winters
Journal:  Emerg Med Clin North Am       Date:  2014-08-28       Impact factor: 2.264

4.  Characterization of Vancomycin Reactions and Linezolid Utilization in the Pediatric Population.

Authors:  Samantha K Lin; Kevin M Mulieri; Faoud T Ishmael
Journal:  J Allergy Clin Immunol Pract       Date:  2017-02-08

Review 5.  The use of vancomycin with its therapeutic and adverse effects: a review.

Authors:  F R Bruniera; F M Ferreira; L R M Saviolli; M R Bacci; D Feder; M da Luz Gonçalves Pedreira; M A Sorgini Peterlini; L A Azzalis; V B Campos Junqueira; F L A Fonseca
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-02       Impact factor: 3.507

6.  No effect of vancomycin powder to prevent infection in primary total knee arthroplasty: a retrospective review of 976 cases.

Authors:  Ibrahim Alper Yavuz; Ozdamar Fuad Oken; Ahmet Ozgur Yildirim; Fatih Inci; Erman Ceyhan; Utku Gurhan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-11-14       Impact factor: 4.342

Review 7.  The use of vancomycin powder in modern spine surgery: systematic review and meta-analysis of the clinical evidence.

Authors:  Joshua Bakhsheshian; Nader S Dahdaleh; Sandi K Lam; Jason W Savage; Zachary A Smith
Journal:  World Neurosurg       Date:  2014-12-19       Impact factor: 2.104

8.  Lactate and venoarterial carbon dioxide difference/arterial-venous oxygen difference ratio, but not central venous oxygen saturation, predict increase in oxygen consumption in fluid responders.

Authors:  Xavier Monnet; Florence Julien; Nora Ait-Hamou; Marie Lequoy; Clément Gosset; Mathieu Jozwiak; Romain Persichini; Nadia Anguel; Christian Richard; Jean-Louis Teboul
Journal:  Crit Care Med       Date:  2013-06       Impact factor: 7.598

9.  Selection pressures of vancomycin powder use in spine surgery: a meta-analysis.

Authors:  Abhiram Gande; Alex Rosinski; Torin Cunningham; Nitin Bhatia; Yu-Po Lee
Journal:  Spine J       Date:  2019-01-17       Impact factor: 4.166

10.  International consensus on (ICON) anaphylaxis.

Authors:  F Estelle R Simons; Ledit Rf Ardusso; M Beatrice Bilò; Victoria Cardona; Motohiro Ebisawa; Yehia M El-Gamal; Phil Lieberman; Richard F Lockey; Antonella Muraro; Graham Roberts; Mario Sanchez-Borges; Aziz Sheikh; Lynette P Shek; Dana V Wallace; Margitta Worm
Journal:  World Allergy Organ J       Date:  2014-05-30       Impact factor: 4.084

View more
  1 in total

1.  Prophylactic Intrawound Vancomycin Powder in Minimally Invasive Spine Stabilization May Cause an Acute Inflammatory Response.

Authors:  Yuki Hyodo; Takeshi Arizono; Akihiko Inokuchi; Takahiro Hamada; Ryuta Imamura
Journal:  Cureus       Date:  2022-09-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.